Aidan at 16:59, 8 April 2026

2026-04-08T16:59:41Z

← Older revision		Revision as of 16:59, 8 April 2026
Line 1:		Line 1:
			{{DISPLAYTITLE:''Mycobacterium kansasii''}}

	== Background ==		== Background ==

Aidan: Created page with "== Background == * Species of non-tuberculous mycobacterium within the genus Genus::Mycobacterium * Slow grower photochromogen * Almost never colonizer, almost always considered pathogenic == Clinical Manifestations == * Causes pulmonary disease, particularly upper lobe cavitary disease in male smokers with alcohol use, often in early 50s * Also causes disseminated disease, particularly in AIDS * Can cause MSK infections == Ma..."

2026-04-08T16:59:25Z

Created page with "== Background == * Species of non-tuberculous mycobacterium within the genus Genus::Mycobacterium * Slow grower photochromogen * Almost never colonizer, almost always considered pathogenic == Clinical Manifestations == * Causes pulmonary disease, particularly upper lobe cavitary disease in male smokers with alcohol use, often in early 50s * Also causes disseminated disease, particularly in AIDS * Can cause MSK infections == Ma..."

New page

== Background ==

* Species of [[Non-tuberculous mycobacteria|non-tuberculous mycobacterium]] within the genus [[Genus::Mycobacterium]]
* Slow grower photochromogen
* Almost never colonizer, almost always considered pathogenic

== Clinical Manifestations ==

* Causes pulmonary disease, particularly upper lobe cavitary disease in male smokers with alcohol use, often in early 50s
* Also causes disseminated disease, particularly in [[AIDS]]
* Can cause MSK infections

== Management ==

* Ideally based on susceptibilities
* Recommended regimen is [[rifampicin]], [[ethambutol]], and either [[isoniazid]] or [[macrolide]]
* Second-line agents would include [[moxifloxacin]] and [[amikacin]] or [[streptomycin]]
* Duration is 12 months, though some experts recommend 12 months following sputum conversion
** Sputum usually negative around 4 months

== Further Reading ==

* Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. ''Eur Respir J''. 2020 Jul 7;56(1):2000535. doi: [https://doi.org/10.1183/13993003.00535-2020 10.1183/13993003.00535-2020]. PMID: [https://pubmed.ncbi.nlm.nih.gov/32636299/ 32636299]; PMCID: [https://pmc.ncbi.nlm.nih.gov/articles/PMC8375621/ PMC8375621].

Mycobacterium kansasii - Revision history

Aidan at 16:59, 8 April 2026